Fig. 2From: Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi ArabiaComparative Annual Treatment Costs of Adalimumab vs. Risankizumab for Plaque Psoriasis: A Perspective from Saudi Arabia’s Public Health SectorBack to article page